Adaptive生物技术

Manufacturing · Biological Products, (No Diagnostic Substances)

完成交易日收盘US$26.83+0.45%行情日期 2026-11-05 · 非实时

公开资料页汇总Adaptive生物技术（ADPT）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-05，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-11-04 — 2026-11-05253 个交易日样本

查看交易日数据

2026-11-05ADPTUS$26.83

查看图表数据

日期	ADPT
2025-11-04	16.92
2025-11-05	17.59
2025-11-06	15.56
2025-11-07	14.79
2025-11-10	14.71
2025-11-11	14.53
2025-11-12	14.5
2025-11-13	14.14
2025-11-14	14.1
2025-11-17	13.71
2025-11-18	13.75
2025-11-19	15.15
2025-11-20	16.32
2025-11-21	18.61
2025-11-24	20.46
2025-11-25	20.32
2025-11-26	19.72
2025-11-28	19.66
2025-12-01	18.84
2025-12-02	18.69
2025-12-03	17.13
2025-12-04	17.46
2025-12-05	14.75
2025-12-08	14.95
2025-12-09	14.86
2025-12-10	15.74
2025-12-11	15.42
2025-12-12	15.44
2025-12-15	15.69
2025-12-16	15.93
2025-12-17	16.12
2025-12-18	16.5
2025-12-19	17
2025-12-22	17.41
2025-12-23	16.75
2025-12-24	16.68
2025-12-26	16.7
2025-12-29	16.65
2025-12-30	16.42
2025-12-31	16.24
2026-01-02	15.91
2026-01-05	16.17
2026-01-06	16.11
2026-01-07	16.73
2026-01-08	15.96
2026-01-09	15.76
2026-01-12	18.26
2026-01-13	18.07
2026-01-14	18.04
2026-01-15	17.78
2026-01-16	17.52
2026-01-20	17.87
2026-01-21	17.57
2026-01-22	19.06
2026-01-23	18.55
2026-01-26	19.12
2026-01-27	19.23
2026-01-28	18.5
2026-01-29	18.37
2026-01-30	18.5
2026-02-02	18.39
2026-02-03	18.5
2026-02-04	17.3
2026-02-05	16.47
2026-02-06	15.77
2026-02-09	15.86
2026-02-10	15.64
2026-02-11	15.62
2026-02-12	15.54
2026-02-13	16.04
2026-02-17	15.79
2026-02-18	15.87
2026-02-19	16.05
2026-02-20	15.2
2026-02-23	15.39
2026-02-24	16.05
2026-02-25	16.21
2026-02-26	16.46
2026-02-27	16.02
2026-03-02	16.12
2026-03-03	16.08
2026-03-04	16.44
2026-03-05	15.93
2026-03-06	14.86
2026-03-09	14.95
2026-03-10	14.52
2026-03-11	14.22
2026-03-12	12.45
2026-03-13	13.17
2026-03-16	13.32
2026-03-17	13.39
2026-03-18	13.28
2026-03-19	13.5
2026-03-20	13.58
2026-03-23	13.66
2026-03-24	13.9
2026-03-25	14.15
2026-03-26	13.96
2026-03-27	12.41
2026-03-30	12.85
2026-03-31	13.88
2026-04-01	14.43
2026-04-02	14.81
2026-04-06	14.08
2026-04-07	13.71
2026-04-08	14.84
2026-04-09	13.4
2026-04-10	12.79
2026-04-13	14.13
2026-04-14	14.53
2026-04-15	14.53
2026-04-16	14.08
2026-04-17	14.47
2026-04-20	14.58
2026-04-21	14.21
2026-04-22	14.2
2026-04-23	13.82
2026-04-24	14.14
2026-04-27	14.21
2026-04-28	14.04
2026-04-29	13.53
2026-04-30	14.1
2026-05-01	14.27
2026-05-04	14.5
2026-05-05	13.78
2026-05-06	14.43
2026-05-07	14.69
2026-05-08	13.81
2026-05-11	13.54
2026-05-12	13.63
2026-05-13	13.13
2026-05-14	13.18
2026-05-15	12.83
2026-05-18	12.71
2026-05-19	12.96
2026-05-20	13.96
2026-05-21	13.87
2026-05-22	13.88
2026-05-26	14.13
2026-05-27	13.84
2026-05-28	15.19
2026-05-29	15.15
2026-06-01	15.23
2026-06-02	15.14
2026-06-03	15.99
2026-06-04	18.08
2026-06-05	16.9
2026-06-08	16.7
2026-06-09	17.36
2026-06-10	17.07
2026-06-11	18.73
2026-06-12	17.6
2026-06-15	17.46
2026-06-16	17.22
2026-06-17	16.78
2026-06-18	17.53
2026-06-22	17.37
2026-06-23	17.23
2026-06-24	19.34
2026-06-25	20.25
2026-06-26	20.96
2026-06-29	21.4
2026-06-30	21.45
2026-07-01	22.37
2026-07-02	21.19
2026-07-06	21.5
2026-07-07	20.82
2026-07-08	20.16
2026-07-09	21.8
2026-07-10	21.06
2026-07-13	21.02
2026-07-14	21.43
2026-07-15	22.9
2026-07-16	22.1
2026-07-17	22.92
2026-07-20	21.86
2026-07-21	22.58
2026-07-22	21.95
2026-07-23	22.31
2026-07-24	22.27
2026-07-27	22.54
2026-07-28	22.52
2026-07-29	22.56
2026-07-30	24.18
2026-07-31	22.57
2026-08-03	23.11
2026-08-04	24.55
2026-08-05	24.6
2026-08-06	23.6
2026-08-07	24.93
2026-08-10	25.45
2026-08-11	25.39
2026-08-12	25.25
2026-08-13	24.46
2026-08-14	24.74
2026-08-17	24.77
2026-08-18	24.56
2026-08-19	25.49
2026-08-20	25.44
2026-08-21	25.99
2026-08-24	25.55
2026-08-25	26.25
2026-08-26	26.16
2026-08-27	26.44
2026-08-28	25.19
2026-08-31	24.92
2026-09-01	24.34
2026-09-02	24.66
2026-09-03	24.57
2026-09-04	24.28
2026-09-08	24.34
2026-09-09	24.42
2026-09-10	24.23
2026-09-11	24.2
2026-09-14	24.78
2026-09-15	26.68
2026-09-16	27.67
2026-09-17	28.55
2026-09-18	28.61
2026-09-21	27.86
2026-09-22	28.06
2026-09-23	27.89
2026-09-24	29.57
2026-09-25	29.43
2026-09-28	28.51
2026-09-29	28.77
2026-09-30	28.9
2026-10-01	27.37
2026-10-02	28.35
2026-10-05	29.84
2026-10-06	26.9
2026-10-07	26.28
2026-10-08	26.09
2026-10-09	26.49
2026-10-12	25.57
2026-10-13	25.28
2026-10-14	25.62
2026-10-15	25.58
2026-10-16	24.02
2026-10-19	23.95
2026-10-20	24.42
2026-10-21	25.33
2026-10-22	24.41
2026-10-23	25.51
2026-10-26	26.27
2026-10-27	27.66
2026-10-28	28.37
2026-10-29	28.17
2026-10-30	26.64
2026-11-02	25.06
2026-11-03	25.8
2026-11-04	26.71
2026-11-05	26.83

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$4.3B

市盈率（TTM）—

自由现金流收益率-1.1%

距52周高点-10.1%

近一年波动率+67.2%

近一年最大回撤-39.3%

区间涨跌幅

10日+9.9%起点 2026-10-22

30日-9.3%起点 2026-09-24

90日+25.1%起点 2026-06-30

180日+67.2%起点 2026-02-19

250日+72.4%起点 2025-11-06

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

查看报告期数据

2025-12-31营收277百万美元

指标	2026-07-31	2026-06-30	2025-12-31	2025-07-31	2025-06-30	2024-12-31	2024-07-29	2024-06-30	2023-12-31
营收	—	—	277	—	—	179	—	—	170.3
净利润	—	—	-59.5	—	—	-159.5	—	—	-225.3
自由现金流	—	—	-48.9	—	—	-98.9	—	—	-167
股份数	159.6	—	—	152.3	—	—	147.5	—	—
债务	—	0	—	—	133.6	—	—	—	—
总资产	—	640.7	—	—	496.6	—	—	584.9	—

客户合同口径 · 营收采用客户合同口径，可能不等同于公司全部收入。

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
CRSPCRISPR治疗	US$4.7B	-14.2%	—	-21.5%	+57.1%
RLAYRelay Therapeutics, Inc.	US$3.8B	+160.3%	—	-18.1%	+64.5%
IOVA艾奥万斯生物治疗	US$3.5B	+235.1%	—	-47.9%	+111.9%
SRRK斯科勒罗克	US$5.6B	+58%	—	-24.2%	+55.6%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。